Wenxin Deng | Social and Cultural Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Wenxin Deng | Social and Cultural Neuroscience | Best Researcher Award

Dr. Wenxin Deng | Soochow University | China

Dr. Wenxin Deng is a distinguished researcher at Soochow University, China, recognized for her contributions to the scientific community through impactful research publications and scholarly influence. She has authored 4 research documents that collectively have been cited in 43 other academic works, reflecting the growing recognition of her research contributions. With an h-index of 3, Dr. Deng’s scholarly output demonstrates both productivity and citation impact within her field. Her research is characterized by a strong commitment to advancing knowledge and fostering innovation across interdisciplinary areas. Through her publications, Dr. Deng has contributed valuable insights that have informed and guided ongoing investigations in her domain. Her academic efforts underscore a dedication to excellence, intellectual curiosity, and the continuous pursuit of solutions to complex scientific challenges. At Soochow University, she continues to play an active role in research development, mentoring, and collaboration, reinforcing her position as a promising academic contributing to China’s and the global scientific community’s advancement.

Profiles: Scopus | Orcid

Featured Publications

Deng, W. (2025). AI and knowledge sharing in team performance: Emotional intelligence as the mediator between coordination and performance. Sustainable Futures.

Deng, W., & Jiang, M. (2025). A multilevel fuzzy AHP model for green furniture evaluation: Enhancing resource efficiency and circular design through lifecycle integration. Systems.

Jiang, M., Deng, W., & Lin, H. (2024). Sustainability through biomimicry: A comprehensive review of bionic design applications. Biomimetics.

Kareem Al-Khalil | Cognitive Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Kareem Al-Khalil | Cognitive Neuroscience | Best Researcher Award

Dr. Kareem Al-Khalil | University of Wisconsin – Madison | United States

Kareem I. Al-Khalil is a Multimodal Imaging Scientist at the Institute on Aging, University of Wisconsin-Madison, with extensive expertise in human development, family sciences, and neuroscience. He earned his Ph.D. in Human Development & Family Sciences, focusing on differences in brain activation and connectivity among college students with varying mathematical abilities, and holds dual M.Sc. degrees in Psychology and Experimental Psychology, as well as a B.Sc. in Biology. His professional trajectory spans postdoctoral research and associate positions at Duke University School of Medicine and the Mind Research Network, where he contributed to understanding neurocognitive processes in psychiatric and behavioral contexts. He has also served as a research analyst, teaching assistant, and graduate instructor, gaining substantial experience in experimental design, psychometrics, and cognitive neuroscience. Al-Khalil’s research contributions include peer-reviewed publications on connectomics, brain network disruption in HIV and substance use, and structural connectivity alterations associated with chronic cannabis use. His work has garnered a total of 201 citations, with an h-index of 8 and an i10-index of 7, reflecting his influence in the fields of cognitive neuroscience and neuroimaging. Through his research, he advances understanding of brain function, network connectivity, and cognitive processes in health and disease, integrating behavioral science with multimodal imaging approaches.

Profiles: Google Scholar | Linked In

Featured Publications

Al-Khalil, K., Vakamudi, K., Witkiewitz, K., & Claus, E. D. (2021). Neural correlates of alcohol use disorder severity among nontreatment‐seeking heavy drinkers: An examination of the incentive salience and negative emotionality domains of the … Alcoholism: Clinical and Experimental Research, 45(6), 1200–1214.

Hou, J., Rajmohan, R., Fang, D., Kashfi, K., Al-Khalil, K., Yang, J., & Westney, W. (2017). Mirror neuron activation of musicians and non-musicians in response to motion captured piano performances. Brain and Cognition, 115, 47–55.

Niehuis, S., Reifman, A., Al-Khalil, K., Oldham, C. R., Fang, D., & O’Boyle, M. (2019). Functional magnetic resonance imaging activation in response to prompts of romantically disillusioning events. Personal Relationships, 26(2), 209–231.

Gonzales, J. U., James, C. R., Yang, H. S., Jensen, D., Atkins, L., & Thompson, B. J. (2016). Different cognitive functions discriminate gait performance in younger and older women: A pilot study. Gait & Posture, 50, 89–95.

Calderon-Delgado, L., Barrera-Valencia, M., Noriega, I., & Al-Khalil, K. (2020). Implicit processing of emotional words by children with post-traumatic stress disorder: An fMRI investigation. International Journal of Clinical and Health Psychology, 20(1), 46–53.

Noriega, I., Trejos-Castillo, E., Chae, Y., & Calderon-Delgado, L. (2021). Emotional memory processing in post‐traumatic stress disorder affected Colombian youth. International Journal of Psychology, 56(3), 387–393.

Kashfi, K., Al-Khalil, K., Hou, J., Fang, D., Anderson, R., Rajmohan, R., & Syapin, P. (2017). Hyper-brain connectivity in binge drinking college students: A diffusion tensor imaging study. Neurocase, 23(3–4), 179–186.

Kashfi, K., Fang, D., Hou, J., Al-Khalil, K., Anderson, R., Syapin, P. J., & O’Boyle, M. W. (2017). Spatial attention in binge-drinking and moderate-drinking college students: An fMRI investigation. Alcoholism Treatment Quarterly, 35(3), 260–278.

Swartz, M., Burton, F., Vakamudi, K., Al-Khalil, K., Witkiewitz, K., & Claus, E. D. (2021). Age dependent neural correlates of inhibition and control mechanisms in moderate to heavy drinkers. NeuroImage: Clinical, 32, 102875.

Yue Ding | Cognitive Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Yue Ding | Cognitive Neuroscience | Best Researcher Award

Dr. Yue Ding | Shanghai Mental Health Center | China

Dr. Yue Ding is a distinguished neuroscientist and biomedical engineer whose research focuses on the neural mechanisms of music and rhythm-based interventions for affective and anxiety disorders, particularly in children and adolescents. With a Ph.D. in Neuroscience from Tsinghua University and a B.S. in Biomedical Engineering from Dalian University of Technology, Dr. Ding has extensive experience in both academic and industry settings, including leadership roles at Shanghai Mental Health Center, AI Institute at iFlytek, and Nielsen Consumer LLC, as well as a visiting scholar position at Johns Hopkins University. Dr. Ding’s research integrates neuroscience, artificial intelligence, and virtual reality to develop personalized interventions, including closed-loop music therapies, rhythm interactive training, and controllable music generation models, supported by numerous national and municipal grants. His work also explores neural oscillations in depression and anxiety, taste perception, and language impairments in Alzheimer’s patients. He is actively involved in professional organizations, including the Art Psychotherapy Committee, Music Psychology Committee, and editorial boards of prominent journals such as Scientific Reports and Frontiers in Psychiatry. With 17 published documents, Dr. Ding has garnered 228 citations and holds an h-index of 8, reflecting his influential contributions to the fields of neuroscience, neuroengineering, and mental health research.

Profiles: Scopus | Google Scholar | Linked In

Featured Publications

Ding, Y., Hu, X., Li, J., Ye, J., Wang, F., & Zhang, D. (2018). What makes a champion: The behavioral and neural correlates of expertise in multiplayer online battle arena games. International Journal of Human–Computer Interaction, 34(8), 682–694.

Ding, Y., Hu, X., Xia, Z., Liu, Y. J., & Zhang, D. (2021). Inter-brain EEG feature extraction and analysis for continuous implicit emotion tagging during video watching. IEEE Transactions on Affective Computing, 12(1), 92–102.

Ding, Y., Zhang, Y., Zhou, W., Ling, Z., Huang, J., Hong, B., & Wang, X. (2019). Neural correlates of music listening and recall in the human brain. Journal of Neuroscience, 39(41), 8112–8123.

Ding, Y., Chu, Y., Liu, M., Ling, Z., Wang, S., Li, X., & Li, Y. (2022). Fully automated discrimination of Alzheimer’s disease using resting-state electroencephalography signals. Quantitative Imaging in Medicine and Surgery, 12(2), 1063–1077.

Ding, Y., Gray, K., Forrence, A., Wang, X., & Huang, J. (2018). A behavioral study on tonal working memory in musicians and non-musicians. PLOS ONE, 13(8), e0201765.

Zhang, Y., Ding, Y., Huang, J., Zhou, W., Ling, Z., Hong, B., & Wang, X. (2021). Hierarchical cortical networks of “voice patches” for processing voices in human brain. Proceedings of the National Academy of Sciences of the United States of America, 118(44), e2103518118.

Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Published on by Neuroscientists

Dr. Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Dr. Efstratios Stylianos Pyrgelis | National and Kapodistrian University of Athens | Greece

Dr. Efstratios-Stylianos Pyrgelis is a distinguished Neurologist and Ph.D. scholar affiliated with the National and Kapodistrian University of Athens. His extensive research contributions span neurochemistry, neuroimaging, and normal pressure hydrocephalus, reflecting a deep commitment to advancing clinical neuroscience. With over 40 published articles in SCI- and Scopus-indexed journals and authorship of 4 international medical books, Dr. Pyrgelis has established a strong academic footprint. His scholarly influence is demonstrated by a total of 510 citations, an h-index of 11, and an i10-index of 12, as recorded on Google Scholar. As a Review Editor for Frontiers in Neurology and Guest Editor for Diagnostics, he plays a pivotal role in shaping contemporary neurological research. He collaborates with the CNS Alliance Research Group and maintains professional memberships with the Greek Neurologic Society and the Medical Association of Chios. Beyond academia, he has contributed to consultancy projects linking research with clinical applications. Through his innovative work and international collaborations, Dr. Pyrgelis continues to contribute significantly to the understanding and treatment of neurological disorders, reinforcing his reputation as one of Greece’s leading researchers in the field of neuroscience.

Profiles: Orcid | Research Gate

Featured Publications

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Stefanis, L., & Kapaki, E. (2024). In vivo prevalence of beta-amyloid pathology and Alzheimer’s disease co-pathology in idiopathic normal-pressure hydrocephalus—Association with neuropsychological features. Biomedicines, 12(8), 1898.

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Papaioannou, M., Stefanis, L., & Kapaki, E. (2023). Alzheimer’s disease CSF biomarkers as possible indicators of tap-test response in idiopathic normal pressure hydrocephalus. Brain Sciences, 13(11), 1593.

Angelopoulou, E., Pyrgelis, E.-S., Ahire, C., Suman, P., Mishra, A., & Piperi, C. (2023). Functional implications of protein arginine methyltransferases (PRMTs) in neurodegenerative diseases. Biology, 12(9), 1257.

Pyrgelis, E.-S., Velonakis, G., Papageorgiou, S. G., Stefanis, L., Kapaki, E., & Constantinides, V. C. (2023). Imaging markers for normal pressure hydrocephalus: An overview. Biomedicines, 11(5), 1265.

Constantinides, V. C., Paraskevas, G. P., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Stefanis, L., & Kapaki, E. (2023). CSF Aβ42 and Aβ42/Aβ40 ratio in Alzheimer’s disease and frontotemporal dementias. Diagnostics, 13(4), 783.

Constantinides, V. C., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Ghika, A., Koros, C., Liakakis, G., Papageorgiou, S., Stefanis, L., Paraskevas, G. P., et al. (2023). Application of the AT(N) and other CSF classification systems in behavioral variant frontotemporal dementia. Diagnostics, 13(3), 332.

Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2022). Emerging potential of the phosphodiesterase (PDE) inhibitor ibudilast for neurodegenerative diseases: An update on preclinical and clinical evidence. Molecules, 27(23), 8448.

Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Yu Zhou is a postdoctoral researcher at Army Engineering University, specializing in the intersection of neuroscience, computer vision, and target detection. His research primarily focuses on deceptive visual design for both human and machine perception, exploring how visual stimuli can influence detection, recognition, and cognitive processing. Zhou has conducted pioneering studies on camouflage and optical deception, utilizing EEG-based brain functional network analysis to evaluate target visibility and cognitive responses. His work integrates principles from weapon science, biomedical engineering, and computer science to develop comprehensive models of visual perception and deception. Representative publications include investigations into neural responses to camouflage targets with varying exposure signs, the impact of color differences on brain activation patterns, and feasibility assessments of optical camouflage effects. Through these studies, he contributes to a deeper understanding of how visual designs can manipulate human attention and computer vision systems, providing actionable insights for defense technology applications. Zhou’s research emphasizes rigorous quantitative evaluation methods, leveraging neurophysiological data to inform the design of effective deceptive visual patterns. With an h-index of 2 and multiple citations, his work demonstrates a growing influence in fields spanning neuroscience-informed computer vision, perceptual deception, and applied optical camouflage.

Profiles: Scopus | Reasearch Gate

Featured publication

Author(s). (2024). Neural responses to camouflage targets with different exposure signs based on EEG. Neuropsychologia.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.

Aikaterini Sousamli | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Aikaterini Sousamli | Behavioral Neuroscience | Best Researcher Award

Dr. Aikaterini Sousamli | University of West Attica | Greece

Aikaterini Sousamli, Midwife, MSc, PhD Candidate at the University of West Attica, is a dedicated healthcare professional and researcher specializing in perinatal health, reproductive medicine, and family planning. She graduated with distinction from the University of Thessaly with an MSc in Primary Health Care and holds a degree in Midwifery from the TEI of Athens. Her doctoral research focuses on perinatal factors associated with the occurrence of Autism Spectrum Disorder (ASD) in children and its impact on family dynamics. Alongside her academic pursuits, she has extensive professional experience as a midwife at the Larissa Health Center and as a research associate in national and international health projects addressing antimicrobial resistance, perinatal care, and global health indicators. She has authored and co-authored numerous peer-reviewed publications in high-impact journals, covering topics such as maternal mental health, menopause, perinatal risk factors for ASD, and sexual health in women with chronic conditions. Her research has been widely cited, with an h-index of 5, 15 scientific documents, and 120 total citations, reflecting her growing academic influence. Active in scientific conferences across Europe, Africa, and Asia, she also serves as a reviewer for the Journal of Gynecology and Obstetrics, contributing to advancing evidence-based midwifery practice globally.

Profiles: Orcid | Research Gate

Featured Publications

Sousamli, A., Vidali, M., Dourou, P., Sarantaki, A., Deltsidou, A., & Vivilaki, V. (2025). Crafting kinship beyond biology: Maternal experiences in non-genetic family formation – A systematic review. MAEDICA – A Journal of Clinical Medicine.

Sousamli, A., Patronidou, D., Taskou, C., Athanasiadou, C.-R., Dourou, P., & Sousamli, A. (2025). The role of the maternal gut microbiome in regulating endocrine function during pregnancy and postpartum: Implications for neonatal health. World Journal of Advanced Research and Reviews, 27(1).

Sousamli, A., Malli, F., Tsaras, K., Dourou, P., Sarantaki, A., & Malliarou, M. (2025). Psychological burden, stress, depression, and resilience among midwives: An epidemiological study in Thessaly, Greece. Journal of Clinical & Basic Psychosomatics.

Sousamli, A., Malliarou, M., Sarantaki, A., Dourou, P., Malli, F., & Tsaras, K. (2025). Psychological burden and burnout among midwives: An epidemiological study in Thessaly, Greece. Journal of Clinical & Basic Psychosomatics.

Sousamli, A. E., & Dourou, P. D. (2025). The impact of menopause on sexual health: A cross-sectional study using data from women living in Northern Greece. World Journal of Advanced Research and Reviews, 26(3).

Sousamli, A. E., & Dourou, P. D. (2025). Association between menopause and quality of life: A cross-sectional study using data from women living in Northern Greece. World Journal of Advanced Research and Reviews, 25(3).

Sousamli, A. E., & Dourou, P. D. (2024). Relationship between episiotomy and dyspareunia: A narrative review of the most recent literature. World Journal of Advanced Research and Reviews, 24(3).

Sousamli, A., Dragioti, E., Metallinou, D., Lykeridou, A., Dourou, P., Athanasiadou, C.-R., Anagnostopoulos, D., & Sarantaki, A. (2024). Perinatal and demographic risk factors associated with autism spectrum disorder: A national survey of potential predictors and severity. Healthcare, 12(20).

Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Assist. Prof. Dr.  Mona Fikry, Faculty of Pharmacy-Cairo University, Egypt.

Dr. Mona Fikry Said, Assistant Professor of Pharmaceutical Chemistry at Cairo University, stands out as a dedicated educator, researcher, and mentor in the field of medicinal chemistry. Her academic journey reflects a blend of deep scientific knowledge and practical teaching expertise. She has supervised numerous postgraduate theses and published extensively in prestigious journals. Her research, particularly in the synthesis and pharmacological evaluation of novel compounds for neurodegenerative diseases, highlights her commitment to addressing real-world health challenges. Beyond her publications, Dr. Said’s influence extends through academic collaboration, curriculum development, and mentorship.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Mona Fikry Said began her academic journey with a strong foundation in pharmaceutical sciences, eventually channeling her passion for medicinal chemistry into advanced academic and research endeavors. Her early commitment to learning laid the groundwork for a career dedicated to both academic excellence and scientific innovation. This formative stage was marked by rigorous study and a growing interest in drug design and discovery, which shaped her professional focus.

🧪 Professional Endeavors

Currently serving as an Assistant Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, Cairo University, Dr. Said has become a respected educator and mentor in her field. She has been actively involved in teaching a wide array of pharmaceutical chemistry courses and guiding numerous master’s and doctoral students through their theses. Her role extends beyond instruction, as she also participates in academic advising and serves as an external examiner for other institutions.

🔬 Contributions and Research Focus

Dr. Said’s research is deeply rooted in pharmaceutical chemistry, with a particular focus on the development of novel bioactive compounds. Her most recent completed project, “Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies,” exemplifies her multidisciplinary approach to drug discovery. She integrates synthesis, pharmacological testing, and computational modeling to explore new therapeutic avenues, especially for neurodegenerative diseases.

🏅 Accolades and Recognition

While not always publicly documented, Dr. Said’s scientific contributions are widely acknowledged through her publications in high-impact journals such as European Journal of Medicinal Chemistry, Molecular Diversity, Bioorganic Chemistry, and Future Medicinal Chemistry. Her expertise is recognized by her academic peers, and her involvement in national academic programs highlights her standing in the pharmaceutical education community.

🌐 Impact and Influence

Through her publications in SCI and Scopus-indexed journals, Dr. Said has significantly contributed to the body of knowledge in pharmaceutical chemistry. Her work bridges theoretical research and practical applications, influencing both the academic landscape and the early stages of pharmaceutical development. By mentoring postgraduate students and collaborating across institutions, she has helped cultivate a new generation of researchers in Egypt and beyond.

📘 Legacy and Future Contributions

Dr. Said’s lasting impact lies not only in her research but also in her educational leadership. With each class she teaches and each thesis she supervises, she sows the seeds for future advancements in medicinal chemistry. Her continued involvement in clinical academic programs and university examinations ensures that her influence will resonate across institutions for years to come. Looking forward, her research aims to expand into more diverse therapeutic targets, further strengthening Cairo University’s role in pharmaceutical innovation.

🧬 Research Vision in Pharmaceutical Chemistry

With an enduring commitment to discovery, Dr. Mona Fikry Said envisions a research future driven by interdisciplinary collaboration and the integration of cutting-edge techniques. Her dedication to the design and synthesis of multitarget agents reflects a broader mission to combat complex diseases like Alzheimer’s. In doing so, she positions herself at the forefront of modern pharmaceutical chemistry, where innovation and impact go hand in hand.

Publication

  • Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents
    FA Ragab, NMA Gawad, HH Georgey, MF Said
    2013

 

  • Design and synthesis of ibuprofen-quinoline conjugates as potential anti-inflammatory and analgesic drug candidates
    AM Ghanim, AS Girgis, BM Kariuki, N Samir, MF Said, A Abdelnaser, …
    2022

 

  • Pyrazolone derivatives: Synthesis, anti-inflammatory, analgesic, quantitative structure–activity relationship and in vitro studies
    FAF Ragab, NM Abdel-Gawad, HH Georgey, MF Said
    2013

 

  • Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII
    RF George, MF Said, S Bua, CT Supuran
    2020

 

  • Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors
    MF Said, RF George, A Petreni, CT Supuran, NM Mohamed
    2022

 

  • Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
    HH Hassanein, HH Georgey, MA Fouad, AM El Kerdawy, MF Said
    2017

 

  • New NSAID conjugates as potent and selective COX-2 inhibitors: Synthesis, molecular modeling and biological investigation
    RM Bokhtia, SS Panda, AS Girgis, N Samir, MF Said, A Abdelnaser, …
    2023

 

  • Development of Isatin‐Based Schiff Bases Targeting VEGFR‐2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies
    IA Seliem, SS Panda, AS Girgis, QL Tran, MF Said, MS Bekheit, …
    2022

 

  • Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential
    MF Said, HH Georgey, ER Mohammed
    2021

 

  • Novel Curcumin Mimics: Design, Synthesis, Biological Properties and Computational Studies of Piperidone‐Piperazine Conjugates
    MA Youssef, SS Panda, DR Aboshouk, MF Said, A El Taweel, M GabAllah, …
    2022

 

✅ Conclusion

Through her unwavering dedication to pharmaceutical chemistry, Dr. Said has carved out a meaningful role in academia and research. Her work not only advances scientific understanding but also nurtures future innovators in the field. With a strong foundation in both teaching and research, and a vision for multidisciplinary innovation, she is poised to continue making impactful contributions to drug discovery and pharmaceutical education in the years to come.